Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy
Iris Wu, Aliya Zeng, Amara Greer-Short, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Ion channel traffic jams: the significance of trafficking deficiency in long QT syndrome
Gema Mondéjar‐Parreño, Ana I. Moreno-Manuel, Juan Manuel Ruiz Robles, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Preclinical efficacy and safety of AAVrh10-based plakophilin-2 gene therapy (LX2020) as a treatment for arrhythmogenic cardiomyopathy
Jing Zhang, Erika J. Gutiérrez-Lara, Aryanne Do, et al.
npj Regenerative Medicine (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Exploring the Therapeutic Potential of Gene Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
Juan Mundisugih, Dhanya Ravindran, Eddy Kizana
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1351-1351
Open Access | Times Cited: 4
Restoration of Sestrin 3 Expression Mitigates Cardiac Oxidative Damage in Ischemia–Reperfusion Injury Model
Mee-Na Park, Sunghye Cho, Dongtak Jeong
Antioxidants (2025) Vol. 14, Iss. 1, pp. 61-61
Open Access
Polo-like kinase inhibitors increase AAV production by halting cell cycle progression
Krishna J. Fisher, Francis Grafton, Francesca Ispaso, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101412-101412
Open Access
Targeting Ventricular Arrhythmias in Non-Ischemic Patients: Advances in Diagnosis and Treatment
Laura Adina Stanciulescu, Maria Dorobanțu, Radu Vătăşescu
Diagnostics (2025) Vol. 15, Iss. 4, pp. 420-420
Open Access
New Insights into Genetic Right Ventricular Cardiomyopathies
Marta Garcia-Montero, Yehia Fanous, Andrew D. Krahn, et al.
Canadian Journal of Cardiology (2025)
Closed Access
Genetics in arrhythmogenic cardiomyopathies: where are we now and where are we heading to?
Andrea Mazzanti, Deni Kukavica, Alessandro Trancuccio, et al.
European Heart Journal Supplements (2025) Vol. 27, Iss. Supplement_1, pp. i98-i102
Open Access
AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models
Amara Greer-Short, Anna Greenwood, Elena C. Leon, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Top stories on advancements in gene therapy for inherited arrhythmogenic diseases: From preclinical studies to initial results in patients
Marina Cerrone
Heart Rhythm (2025) Vol. 22, Iss. 4, pp. 1125-1126
Closed Access
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management
Steven A. Muller, Giorgia Bertoli, Jianan Wang, et al.
Journal of Cardiovascular Electrophysiology (2024)
Open Access | Times Cited: 3
CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice
Carolin Lerchenmüller, Margaret H. Hastings, Charles P. Rabolli, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3683-3694
Closed Access | Times Cited: 2
Cardiomyopathy: pathogenesis and therapeutic interventions
Shitong Huang, Jiaxin Li, Qiuying Li, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Efficient AAV9 Purification Using a Single-Step AAV9 Magnetic Affinity Beads Isolation
Kian Chuan Sia, Zhen Ying Fu, Siti Humairah Mohd Rodhi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8342-8342
Open Access | Times Cited: 1
Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review
Caterina Micolonghi, Federica Perrone, Marco Fabiani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9787-9787
Open Access | Times Cited: 1
Atrial cardiomyopathy resulting from loss of plakophilin‐2 expression: Response to adrenergic stimulation and implications for the exercise response
Kavya Phadke, Sebastiano D’Anna, Estefanía Torres-Vega, et al.
The Journal of Physiology (2024)
Closed Access | Times Cited: 1
Animal Models and Molecular Pathogenesis of Arrhythmogenic Cardiomyopathy Associated with Pathogenic Variants in Intercalated Disc Genes
Sara Vencato, Chiara Romanato, Alessandra Rampazzo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6208-6208
Open Access
Revolutionizing Cardiac Care: The Role of Gene Therapy in Treating Cardiomyopathy
Dev Desai, Darshil Kumar Maheta, Siddharth Agrawal, et al.
Cardiology in Review (2024)
Closed Access
The Intra-Articular Delivery of a Low-Dose Adeno-Associated Virus-IL-1 Receptor Antagonist Vector Alleviates the Progress of Arthritis in an Osteoarthritis Rat Model
Shuang Luo, Hao Jiang, Qingwei Li, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1518-1518
Open Access
Latest Developments in Gene Therapy for Heart Failure
Cameron Andrew Olandt, Cody Kelso, Kimberly N. Hong, et al.
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 27, Iss. 1
Closed Access
Toward Precision Medicine in the Treatment of Arrhythmogenic Cardiomyopathy
Michael B. Liu, Victoria N. Parikh
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 26, Iss. 11, pp. 317-330
Closed Access
Page 1

Scroll to top